<VariationArchive VariationID="637" VariationName="NM_000277.1(PAH):c.913_1199del (p.Ile306Leufs)" VariationType="Deletion" Accession="VCV000000637" Version="83" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-01" DateCreated="2015-04-26" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="15676" VariationID="637">
      <GeneList>
        <Gene Symbol="LOC126861615" FullName="CDK7 strongly-dependent group 2 enhancer GRCh37_chr12:103244689-103245888" GeneID="126861615" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>12q23.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="102850911" stop="102852110" display_start="102850911" display_stop="102852110" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="PAH" FullName="phenylalanine hydroxylase" GeneID="5053" HGNC_ID="HGNC:8582" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q23.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="102836889" stop="102958441" display_start="102836889" display_stop="102958441" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="103232103" stop="103311380" display_start="103232103" display_stop="103311380" Strand="-" />
          </Location>
          <OMIM>612349</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000277.1(PAH):c.913_1199del (p.Ile306Leufs)</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q23.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" outerStart="102840516" innerStart="102843645" innerStop="102846952" outerStop="102851686" display_start="102840516" display_stop="102851686" variantLength="3308" />
      </Location>
      <OtherNameList>
        <Name>NM_000277.1(PAH):c.913_1199del</Name>
        <Name>EX9-11DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="protein">
          <ProteinExpression sequenceAccessionVersion="NP_000268.1" sequenceAccession="NP_000268" sequenceVersion="1" change="p.Ile306Leufs">
            <Expression>NP_000268.1:p.Ile306Leufs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="U49897.1" sequenceAccession="U49897" sequenceVersion="1" change="c.916_1202del">
            <Expression>U49897.1:c.916_1202del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008690.2" sequenceAccession="NG_008690" sequenceVersion="2" change="g.(111725_116459)_(119766_122895)del">
            <Expression>NG_008690.2:g.(111725_116459)_(119766_122895)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.(102840516_102843645)_(102846952_102851686)del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.(102840516_102843645)_(102846952_102851686)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="612349.0064" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000277.1(PAH):c.913_1199del (p.Ile306Leufs) AND Phenylketonuria" Accession="RCV000000669" Version="79">
        <ClassifiedConditionList TraitSetID="159">
          <ClassifiedCondition DB="MedGen" ID="C0031485">Phenylketonuria</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2019-07-14" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-07-14" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2015-04-26" MostRecentSubmission="2024-05-01">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10472529</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/966b80c9-3cc5-47be-99a6-567f7321d534</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="159" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3795" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Phenylketonurias</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Phenylketonuria</ElementValue>
                <XRef ID="Phenylketonuria/5714" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009861" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Oligophrenia phenylpyruvica</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Folling disease</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PKU</ElementValue>
                <XRef Type="MIM" ID="261600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330994" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000505064" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592287" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000560957" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529111" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000505124" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529346" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000506557" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000260641" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507953" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000596351" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7383" />
                <XRef ID="7383" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Phenylalanine hydroxylase (PAH) deficiency results in intolerance to the dietary intake of the essential amino acid phenylalanine and produces a spectrum of disorders. The risk of adverse outcome varies based on the degree of PAH deficiency. Without effective therapy, most individuals with severe PAH deficiency, known as classic PKU, develop profound and irreversible intellectual disability. Affected individuals on an unrestricted diet who have phenylalanine levels above normal but below 1,200 Âµmol/L (20 mg/dL) are at much lower risk for impaired cognitive development in the absence of treatment.</Attribute>
                <XRef ID="NBK1504" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301677</ID>
                <ID Source="BookShelf">NBK1504</ID>
              </Citation>
              <Citation Type="general" Abbrev="USPSTF, 2008">
                <ID Source="pmc">2267416</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21915151</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2014">
                <ID Source="PubMed">24385074</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2014">
                <ID Source="pmc">3918542</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Camp et al., 2014">
                <ID Source="PubMed">24667081</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="GMDI/SERN, 2022">
                <URL>https://managementguidelines.net/guidelines.php/136/PKU%20Nutrition%20Guidelines/Version%202.5</URL>
                <CitationText>PKU Nutrition Management Guidelines</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Phenylalanine.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated Phenylalanine, Phenylalanine hydroxylase deficiency (PAH), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Phenylalanine-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, PAH deficiency: Elevated Phenylalanine, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Adult-PKU.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Adult Genetics Disease ACT Sheet, Adult Phenylketonuria (PKU), 2012</CitationText>
              </Citation>
              <XRef ID="716" DB="Orphanet" />
              <XRef ID="C0031485" DB="MedGen" />
              <XRef ID="MONDO:0009861" DB="MONDO" />
              <XRef Type="MIM" ID="261600" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="20819" SubmissionDate="2015-04-23" DateLastUpdated="2024-05-01" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="612349.0064_PHENYLKETONURIA" title="PAH, EX9-11DEL_PHENYLKETONURIA" />
        <ClinVarAccession Accession="SCV000020819" DateUpdated="2024-05-01" DateCreated="2013-04-04" Type="SCV" Version="67" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1999-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">For discussion of the deletion involving exons 9, 10, and 11 of the PAH gene that was found in compound heterozygous state in a patient with phenylketonuria (PKU; 261600) by Zschocke et al. (1999), see 612349.0051.</Attribute>
              <Citation>
                <ID Source="PubMed">10472529</ID>
              </Citation>
              <XRef DB="OMIM" ID="261600" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PAH" />
          </GeneList>
          <Name>PAH, EX9-11DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">EX9-11DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="612349.0064" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PHENYLKETONURIA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="2260701" SubmissionDate="2019-10-07" DateLastUpdated="2020-01-20" DateCreated="2020-01-20">
        <ClinVarSubmissionID localKey="966b80c9-3cc5-47be-99a6-567f7321d534" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001146698" DateUpdated="2020-01-20" DateCreated="2020-01-20" Type="SCV" Version="1" SubmitterName="ClinGen PAH Variant Curation Expert Panel" OrgID="506558" OrganizationCategory="consortium" OrgAbbreviation="PAH_EP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-07-14">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10472529</ID>
          </Citation>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/966b80c9-3cc5-47be-99a6-567f7321d534</URL>
          </Citation>
          <Comment>The c.913_1199del (p.Ile306Leufs) variant in PAH has been previously reported in a proband with mild PKU; BH4 deficiency does not appear to have been excluded (PP4). It was found in trans (confirmed via paternal testing) with the known Pathogenic variant p.Glu390Gly (see ClinVar ID 625, PM3). The sequence change results a deletion involving exons 9, 10 and 11 leading to a frameshift variant in the in the canonical transcript of PAH, a gene fulfilling the most recent criteria for LOF being a known disease mechanism (see PMID: 30192042) (PVS1). It is absent from control databases (PM2). ). In summary, this variant meets criteria to be classified as pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PVS1, PM2, PM3, PP4.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen PAH ACMG Specifications v1</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/blqqhvgi/clingen_pah_acmg_specifications_v1.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PAH" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000277.1(PAH):c.913_1199del</Name>
            <Name>p.Ile306Leufs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000277.1:c.913_1199del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA716" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6397269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2260701" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA716" MappingRef="Orphanet">
        <MedGen CUI="C0031485" Name="Phenylketonuria" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="20819" TraitType="Disease" MappingType="Name" MappingValue="PHENYLKETONURIA" MappingRef="Preferred">
        <MedGen CUI="C0031485" Name="Phenylketonuria" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

